Tempest Therapeutics (TPST) Registration Filing summary

Company overview and business model

• Incorporated in Delaware with principal executive offices in Brisbane, California.

• Registers a variety of securities, including common stock, preferred stock, debt securities, warrants, units, and rights to purchase these securities.

Management team and governance

• Stephen Brady serves as President, Chief Executive Officer, and Director.

• Nicholas Maestas is Chief Financial Officer; Justin Trojanowski is Corporate Controller and Treasurer.

• Board includes Michael Raab (Chairman), Christine Pellizzari, Geoff Nichol, and Ronit Simantov.

Offering details and pricing

• Registration statement filed on Form S-3 for a shelf offering, allowing for delayed or continuous sales under Rule 415.

• Amendment modifies the amount of unsold securities and updates consents and exhibits.

• Estimated SEC registration fee is $45,930; other expenses include accounting, legal, transfer agent, trustee, and printing fees.